López-Fernández Yolanda M, Martínez-de-Azagra Amelia, Reyes-Domínguez Susana B, Gómez-Zamora Ana, Herrera-Castillo Laura, Coca-Pérez Ana, Parrilla-Parrilla Julio, Medina Alberto, García-Iñiguez Juan P, Brezmes-Raposo Marta, Hernández-Yuste Alexandra, Llorente de la Fuente Ana M, Ibarra de la Rosa Ignacio, León-González José S, Trastoy-Quintela Javier, Arjona-Villanueva David, González-Martín Jesús M, Szakmany Tamas, Villar Jesús
Pediatric Intensive Care Unit, Department of Pediatrics, Cruces University Hospital, Biocruces-Bizkaia Health Research Institute, Bizkaia, Spain.
Pediatric Intensive Care Unit, Niño Jesús University Hospital, Madrid, Spain.
Pediatr Crit Care Med. 2025 Jun 1;26(6):e759-e772. doi: 10.1097/PCC.0000000000003743. Epub 2025 Apr 25.
To describe the epidemiology and outcome of children with acute hypoxemic respiratory failure (AHRF) and/or pediatric acute respiratory distress syndrome (PARDS).
Prospective, observational study in six nonconsecutive 2-month blocks form October 2019 to September 2021.
A network of 22 PICUs in Spain.
Consecutive children (7 d to 15 yr old) with a diagnosis of AHRF, defined by Pa o2 /F io2 ratio less than or equal to 300 mm Hg, who needed invasive mechanical ventilation (IMV) using positive end-expiratory pressure (PEEP) greater than or equal to 5 cm H 2 O and F io2 greater than or equal to 0.3.
None.
The primary outcomes were AHRF prevalence and PICU mortality. The secondary outcomes were the prevalence of IMV with PARDS (IMV-PARDS) and the use of adjunctive therapies. There were 6545 PICU admissions: 1374 (21%) underwent IMV and 181 (2.8%) had AHRF. Ninety-one patients (1.4% of PICU admissions, 6.6% of IMV cases, and 50.3% of AHRF cases) met the Second Pediatric Acute Lung Injury Consensus Conference IMV-PARDS criteria. At baseline, mean (± sd ) tidal volume was 7.4 ± 1.8 mL/kg ideal body weight, PEEP 8.4 ± 3.1 cm H 2 O, F io2 0.68 ± 0.23, and plateau pressure 25.7 ± 6.3 cm H 2 O. Unlike patients with PARDS, adjunctive therapies were used infrequently in non-PARDS AHRF patients. AHRF patients without PARDS had more ventilator-free days than PARDS patients (16.4 ± 9.4 vs. 11.2 ± 10.5; p = 0.002). All-cause PICU mortality in AHRF cases was higher in PARDS vs. non-PARDS patients (30.8% [95% CI, 21.5-41.3] vs. (14.4% [95% CI, 7.9-23.4]; p = 0.01).
In our 2019-2021 PICU population, the prevalence of AHRF is 2.8% of IMV cases. Of such patients, the prevalence of PARDS was 50.3%, and there was a 30.8% mortality, which was higher than in cases of AHRF without PARDS.
描述急性低氧性呼吸衰竭(AHRF)和/或儿童急性呼吸窘迫综合征(PARDS)患儿的流行病学特征及预后。
于2019年10月至2021年9月期间进行的一项前瞻性观察性研究,分六个不连续的2个月时间段进行。
西班牙22个儿科重症监护病房(PICU)组成的网络。
连续纳入诊断为AHRF的儿童(7天至15岁),其定义为动脉血氧分压(PaO₂)/吸入氧分数值(FiO₂)≤300 mmHg,且需要使用呼气末正压(PEEP)≥5 cmH₂O和FiO₂≥0.3进行有创机械通气(IMV)。
无。
主要结局为AHRF患病率和PICU死亡率。次要结局为合并PARDS的IMV(IMV-PARDS)患病率及辅助治疗的使用情况。共有6545例患儿入住PICU:1374例(21%)接受了IMV,181例(2.8%)患有AHRF。91例患者(占PICU入院患者的1.4%、IMV病例的6.6%以及AHRF病例的50.3%)符合第二届儿童急性肺损伤共识会议的IMV-PARDS标准。基线时,平均(±标准差)潮气量为7.4±1.8 mL/kg理想体重,PEEP为8.4±3.1 cmH₂O,FiO₂为0.68±0.23,平台压为25.7±6.3 cmH₂O。与PARDS患者不同,非PARDS的AHRF患者较少使用辅助治疗。未合并PARDS的AHRF患者无呼吸机天数多于PARDS患者(16.4±9.4天 vs. 11.2±10.5天;p = 0.002)。PARDS的AHRF病例全因PICU死亡率高于非PARDS患者(30.8% [95%CI,21.5 - 41.3] vs. 14.4% [95%CI,7.9 - 23.4];p = 0.01)。
在我们2019 - 2021年的PICU人群中,AHRF患病率为IMV病例的2.8%。在这些患者中,PARDS患病率为50.3%,死亡率为30.8%,高于未合并PARDS的AHRF病例。